|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.60 INR | 0.00% |
|
+4.16% | -15.28% |
| 05-26 | Ramdevbaba Solvent Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 04-08 | Ramdevbaba Solvent Ltd says unit commences ethanol dispatch to oil marketing companies | RE |
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 6.91 | 8.77 | 8.12 | 4.19 | 3.01 | ||||
Return on Total Capital | 9.04 | 11.45 | 10.31 | 4.77 | 3.37 | ||||
Return On Equity % | 20.6 | 31.46 | 21.61 | 11.79 | 6.74 | ||||
Return on Common Equity | 20.6 | 31.46 | 21.61 | 13.38 | 7.27 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 15.91 | 16.05 | 17.36 | 14.28 | 17.12 | ||||
SG&A Margin | 1.43 | 0.97 | 1.4 | 1.18 | 1.5 | ||||
EBITDA Margin % | 2.89 | 3.56 | 4.59 | 3.45 | 3.8 | ||||
EBITA Margin % | 2.17 | 3.24 | 3.97 | 2.93 | 3.16 | ||||
EBIT Margin % | 2.17 | 3.24 | 3.97 | 2.93 | 3.16 | ||||
Income From Continuing Operations Margin % | 1.14 | 1.86 | 1.9 | 1.61 | 1.39 | ||||
Net Income Margin % | 1.14 | 1.86 | 1.9 | 1.62 | 1.39 | ||||
Net Avail. For Common Margin % | 1.14 | 1.86 | 1.9 | 1.62 | 1.39 | ||||
Normalized Net Income Margin | 0.78 | 1.51 | 1.61 | 1.35 | 1.25 | ||||
Levered Free Cash Flow Margin | - | -5.17 | -2.5 | -14.86 | -12.34 | ||||
Unlevered Free Cash Flow Margin | - | -4.69 | -1.64 | -14.34 | -11.61 | ||||
Asset Turnover | |||||||||
Asset Turnover | 5.1 | 4.34 | 3.27 | 2.29 | 1.52 | ||||
Fixed Assets Turnover | 12.73 | 9.84 | 7.36 | 4.06 | 2.73 | ||||
Receivables Turnover (Average Receivables) | 25.07 | 20.97 | 17.31 | 25.47 | 25.27 | ||||
Inventory Turnover (Average Inventory) | 13.67 | 14.27 | 10.47 | 11.45 | 6.37 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 1.5 | 1.02 | 1.03 | 1.55 | 1.31 | ||||
Quick Ratio | 0.57 | 0.48 | 0.46 | 0.69 | 0.16 | ||||
Operating Cash Flow to Current Liabilities | - | 0.11 | 0.04 | -0.01 | -0.27 | ||||
Days Sales Outstanding (Average Receivables) | 14.56 | 17.41 | 21.15 | 14.33 | 14.44 | ||||
Days Outstanding Inventory (Average Inventory) | 26.71 | 25.58 | 34.96 | 31.88 | 57.32 | ||||
Average Days Payable Outstanding | 13.59 | 15.77 | 19.36 | 14.05 | 13.79 | ||||
Cash Conversion Cycle (Average Days) | 27.67 | 27.21 | 36.75 | 32.16 | 57.98 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 182.5 | 207.45 | 152.37 | 162.89 | 204.72 | ||||
Total Debt / Total Capital | 64.6 | 67.47 | 60.38 | 61.96 | 67.18 | ||||
LT Debt/Equity | 120.03 | 88.41 | 48.83 | 120.51 | 118.55 | ||||
Long-Term Debt / Total Capital | 42.49 | 28.76 | 19.35 | 45.84 | 38.91 | ||||
Total Liabilities / Total Assets | 72.37 | 74.91 | 68.25 | 66.02 | 70.71 | ||||
EBIT / Interest Expense | 2.78 | 4.28 | 2.87 | 3.49 | 2.73 | ||||
EBITDA / Interest Expense | 3.71 | 4.71 | 3.32 | 4.11 | 3.29 | ||||
(EBITDA - Capex) / Interest Expense | 3.71 | -2.77 | 2.09 | -12.13 | 0.16 | ||||
Total Debt / EBITDA | 3.86 | 3.99 | 3.52 | 8.33 | 11.46 | ||||
Net Debt / EBITDA | 3.85 | 3.98 | 3.51 | 8.19 | 11.42 | ||||
Total Debt / (EBITDA - Capex) | 3.86 | -6.78 | 5.59 | -2.82 | 233.36 | ||||
Net Debt / (EBITDA - Capex) | 3.85 | -6.76 | 5.58 | -2.78 | 232.57 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 37.5 | 19.65 | -1.64 | 35.28 | -11.35 | ||||
Gross Profit, 1 Yr. Growth % | 16.46 | 17.21 | 9.22 | 11.26 | 3.88 | ||||
EBITDA, 1 Yr. Growth % | 12.35 | 36.11 | 17.36 | 1.52 | -5.08 | ||||
EBITA, 1 Yr. Growth % | 17.21 | 72.25 | 10.69 | -0.3 | -7.67 | ||||
EBIT, 1 Yr. Growth % | 17.21 | 72.25 | 10.69 | -0.3 | -7.67 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 15.6 | 97.25 | -11.27 | 14.9 | -23.67 | ||||
Net Income, 1 Yr. Growth % | 15.6 | 97.25 | -11.27 | 15.11 | -23.8 | ||||
Normalized Net Income, 1 Yr. Growth % | 6.37 | 111.79 | -7.03 | 13.16 | -18.17 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 15.6 | 97.25 | -19.4 | -20.23 | -27.15 | ||||
Accounts Receivable, 1 Yr. Growth % | 49.29 | 38.99 | 4.92 | -20.47 | 1.74 | ||||
Inventory, 1 Yr. Growth % | -3.63 | 33.33 | 31 | 26.25 | 76.14 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 33.31 | 71.08 | 8.28 | 72.38 | 8.42 | ||||
Total Assets, 1 Yr. Growth % | 29.9 | 45.13 | 20.21 | 46.66 | 24.1 | ||||
Tangible Book Value, 1 Yr. Growth % | 22.97 | 37.33 | 52.11 | 106.05 | 7.6 | ||||
Common Equity, 1 Yr. Growth % | 22.97 | 37.33 | 52.11 | 108.21 | 7.54 | ||||
Cash From Operations, 1 Yr. Growth % | - | 316.3 | -54.47 | -96.75 | 7.5K | ||||
Capital Expenditures, 1 Yr. Growth % | - | 116.64 | -70.41 | 52.85 | -76.47 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | - | 60.55 | -50.33 | 25.61 | -26.16 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | - | 67.44 | -64.05 | 28.09 | -27.84 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 29.25 | 28.26 | 8.48 | 15.35 | 9.5 | ||||
Gross Profit, 2 Yr. CAGR % | 19.09 | 16.94 | 11.66 | 10.24 | 8.73 | ||||
EBITDA, 2 Yr. CAGR % | 15.39 | 23.83 | 31.37 | 9.15 | -0.39 | ||||
EBITA, 2 Yr. CAGR % | 14.26 | 37.16 | 44.19 | 5.05 | -2.4 | ||||
EBIT, 2 Yr. CAGR % | 14.26 | 37.16 | 44.19 | 5.05 | -2.4 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 14.5 | 45.16 | 40.61 | 0.97 | -6.35 | ||||
Net Income, 2 Yr. CAGR % | 14.5 | 45.16 | 40.61 | 1.06 | -6.34 | ||||
Normalized Net Income, 2 Yr. CAGR % | 8.15 | 42.38 | 49.17 | 2.57 | -3.58 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 14.49 | 45.22 | 34 | -19.82 | -23.75 | ||||
Accounts Receivable, 2 Yr. CAGR % | 12.76 | 44.05 | 20.76 | -8.65 | -10.05 | ||||
Inventory, 2 Yr. CAGR % | 21.26 | 13.35 | 32.16 | 28.6 | 49.12 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 31.64 | 51.01 | 36.11 | 79.82 | 36.71 | ||||
Total Assets, 2 Yr. CAGR % | 27.15 | 37.21 | 32.09 | 59.01 | 34.91 | ||||
Tangible Book Value, 2 Yr. CAGR % | 23.88 | 30.15 | 44.53 | 77.04 | 48.9 | ||||
Common Equity, 2 Yr. CAGR % | 23.88 | 30.15 | 44.53 | 77.96 | 49.63 | ||||
Cash From Operations, 2 Yr. CAGR % | - | -3.11 | 38.29 | -74.05 | 57.16 | ||||
Capital Expenditures, 2 Yr. CAGR % | - | 72.27 | -19.95 | 78.94 | -40.03 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | - | 126.11 | -12.53 | 99.71 | -3.86 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | 162.26 | -24.15 | 106.2 | -4.09 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 43 | 26.01 | 17.4 | 16.77 | 5.65 | ||||
Gross Profit, 3 Yr. CAGR % | 32.11 | 19.68 | 13.3 | 11.52 | 8.9 | ||||
EBITDA, 3 Yr. CAGR % | 21.11 | 25.21 | 24.81 | 20.56 | 5.21 | ||||
EBITA, 3 Yr. CAGR % | 25.1 | 32.7 | 31.44 | 27.5 | 1.78 | ||||
EBIT, 3 Yr. CAGR % | 25.1 | 32.7 | 31.44 | 27.5 | 1.78 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 21.49 | 36.76 | 28.3 | 31.46 | -8.02 | ||||
Net Income, 3 Yr. CAGR % | 21.49 | 36.76 | 28.3 | 31.54 | -8.01 | ||||
Normalized Net Income, 3 Yr. CAGR % | 25.54 | 39.22 | 28.67 | 36.05 | -4.74 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 21.49 | 36.75 | 24.28 | 12.72 | -22.33 | ||||
Accounts Receivable, 3 Yr. CAGR % | 38.68 | 20.9 | 29.61 | 5.07 | -5.31 | ||||
Inventory, 3 Yr. CAGR % | 23.21 | 25.16 | 18.95 | 30.16 | 42.81 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 20.05 | 43.71 | 35.16 | 76.86 | 51.91 | ||||
Total Assets, 3 Yr. CAGR % | 26.79 | 33.64 | 31.29 | 54.24 | 46.4 | ||||
Tangible Book Value, 3 Yr. CAGR % | 23.47 | 27.19 | 37.09 | 62.66 | 49.96 | ||||
Common Equity, 3 Yr. CAGR % | 23.47 | 27.19 | 37.09 | 63.23 | 50.46 | ||||
Cash From Operations, 3 Yr. CAGR % | - | 49.65 | -24.45 | -34.35 | 72.36 | ||||
Capital Expenditures, 3 Yr. CAGR % | - | 137.3 | -4.25 | 90.71 | -9.01 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 54.22 | 34.56 | 83.15 | 43.17 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 60.94 | 33.2 | 89.49 | 45.07 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 30.84 | 28.07 | 21.63 | 14.17 | ||||
Gross Profit, 5 Yr. CAGR % | - | 26.67 | 24.27 | 15.2 | 11.45 | ||||
EBITDA, 5 Yr. CAGR % | - | 25.67 | 27.13 | 20.37 | 14.04 | ||||
EBITA, 5 Yr. CAGR % | - | 28.72 | 33.43 | 22.97 | 16.68 | ||||
EBIT, 5 Yr. CAGR % | - | 28.72 | 33.43 | 22.97 | 16.68 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 31.97 | 28.53 | 24.12 | 13.12 | ||||
Net Income, 5 Yr. CAGR % | - | 31.97 | 28.53 | 24.17 | 13.13 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 28.35 | 36.82 | 26.26 | 14.64 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 31.97 | 26.07 | 13.18 | 2.22 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 33.1 | 31.21 | 8.08 | 11.99 | ||||
Inventory, 5 Yr. CAGR % | - | 40.14 | 26.71 | 26.52 | 30.21 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 31.53 | 26.26 | 57.19 | 51.55 | ||||
Total Assets, 5 Yr. CAGR % | - | 33.68 | 29.33 | 43.27 | 42.65 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 25.71 | 30.87 | 45.18 | 41.7 | ||||
Common Equity, 5 Yr. CAGR % | - | 25.71 | 30.87 | 45.48 | 41.98 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 2.79 | 7.63 | -25.61 | 37.13 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 29.67 | 2.08 | 111.96 | 17.45 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 9.07 | 69.61 | 70.47 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 3.68 | 76.11 | 82.19 |
- Stock Market
- Stocks
- RBS Stock
- Financials Ramdevbaba Solvent Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















